Literature DB >> 28736278

Efficacy paradox and proportional contextual effect (PCE).

Weiya Zhang1, Michael Doherty2.   

Abstract

The "efficacy paradox" is when the effect of a treatment tested in an RCT, or evidence-based guideline advice, differs markedly from treatment benefits observed in clinical practice. This arises because in RCT reporting and guideline development treatment efficacy is judged by the separation of the treatment group from the placebo group (the specific treatment effect) whereas in clinical practice it is the overall treatment effect, which includes both specific and contextual responses, that patients experience. This paradox causes a disconnect between guidelines and clinical practice and ignores the importance of contextual response in clinical care. This article fully explains and discusses these issues and presents a possible way to reduce the paradox through an alteration in RCT reporting that shifts the focus to overall treatment benefit and the proportion ("proportional contextual effect") that is explained by placebo and contextual effects.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28736278     DOI: 10.1016/j.clim.2017.07.018

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

Review 1.  Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis.

Authors:  Julia Prinz; Nicola Maffulli; Matthias Fuest; Peter Walter; Frank Hildebrand; Filippo Migliorini
Journal:  Int J Clin Pharm       Date:  2022-08-08

2.  Attempting to Separate Placebo Effects from Exercise in Chronic Pain: A Systematic Review and Meta-analysis.

Authors:  Clint T Miller; Patrick J Owen; Christian A Than; Jake Ball; Kate Sadler; Alessandro Piedimonte; Fabrizio Benedetti; Daniel L Belavy
Journal:  Sports Med       Date:  2021-08-27       Impact factor: 11.928

3.  Effect of a valgus brace on medial tibiofemoral joint contact force in knee osteoarthritis with varus malalignment: A within-participant cross-over randomised study with an uncontrolled observational longitudinal follow-up.

Authors:  Michelle Hall; Scott Starkey; Rana S Hinman; Laura E Diamond; Gavin K Lenton; Gabrielle Knox; Claudio Pizzolato; David J Saxby
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

Review 4.  Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain.

Authors:  Giacomo Rossettini; Elisa Carlino; Marco Testa
Journal:  BMC Musculoskelet Disord       Date:  2018-01-22       Impact factor: 2.362

5.  Corticosteroid injection for plantar heel pain: a systematic review and meta-analysis.

Authors:  Glen A Whittaker; Shannon E Munteanu; Hylton B Menz; Daniel R Bonanno; James M Gerrard; Karl B Landorf
Journal:  BMC Musculoskelet Disord       Date:  2019-08-17       Impact factor: 2.362

6.  Predicting response to topical non-steroidal anti-inflammatory drugs in osteoarthritis: an individual patient data meta-analysis of randomized controlled trials.

Authors:  Monica S M Persson; Joanne Stocks; Gyula Varadi; Mohammad Hashem Hashempur; Marienke van Middelkoop; Sita Bierma-Zeinstra; David A Walsh; Michael Doherty; Weiya Zhang
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

Review 7.  Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects.

Authors:  Sigurlaug H Hafliðadóttir; Carsten B Juhl; Sabrina M Nielsen; Marius Henriksen; Ian A Harris; Henning Bliddal; Robin Christensen
Journal:  Trials       Date:  2021-07-26       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.